A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects

NCT05294536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide injection,RD12014
DRUG: Liraglutide injection,Victoza

Sponsor

Sunshine Lake Pharma Co., Ltd.